The Helsinki Declaration Up to now there are no generally accepted ethical guidelines for controlled studies. The issue is hardly discussed in the Helsinki Declaration even in its last version. The reason might be that in many of these studies it is difficult to determine whether to classify them as 'mere patient-care' or as research. If they are to be considered as mere patient-care, the doctor is under the obligation to answer for his action to the medical authorities involved, but if they are to be characterised as research experiment they have, in accordance with the Helsinki Declaration, also to be scrutinised by an independent ethical committee.
The original version of this Declaration (I964)-that in its essential features has been adopted in most countries, at least in Europe-addressed itself directly to the clinical investigator, who it was assumed would himself make the necessary ethical deliberations. Under these circumstances it was immaterial whether a measure was designated as patient-care or as research. In 75 of the papers, reports were made of experiences with new diagnostic aids and therapeutic methods. The new procedures were applied in routine medical care and no more comprehensive steps were taken for demonstrating the value of the measures.
In most of these cases, the doctor in question considered the adopted measures to be medically indicated. The measures thus did not entail any departure from what was justified from the patientcare angle. Since this was a matter of medically based measures performed under medical responsibility, these cases ought not, in my opinion, to be introduced under the concept of biomedical experiments. It would probably lead to untenable consequences if we in Sweden were to get a number of authorities-the ethical committees-assigned to decide which measures were in line with the requirement of the medical regulation for-as we say-'science and tested experience'. In Sweden this is a task for the National Board of Health and Welfare.
However, situations exist where testing can be required. Such is the case when a doctor wishes to use a new method whose reliability he feels unable to judge and where he is thus himself doubtful of the value of the method in question.
The basic rule ought to be that the doctor in charge should be entrusted with the duty of himself deciding when a medical-care measure needs to be evaluated from an ethical view-point. The situation varies however, in the evaluation of surgical and similar procedures and of some medical principles of treatment. As regards operative technique it isat least in Sweden-most often primarily the operator in cooperation with the staff of the clinic who, on the basis of their experience and knowledge, are best equipped to judge the situation in question. As regards new drugs, the individual doctor or clinical staff would usually find it difficult to assess their advantages or disadvantages. Therefore in most countries, as in Sweden, the testing of new drugs is surrounded by special regulations.
In 1 I5 of the papers, studies were reported where measures were adopted which were not necessary solely from the standpoint of the patient's situation, but where the aim undoubtedly was to elucidate the nature of the disease concerned or to create a basis for improved diagnostics and therapy. Thus, patient-care and research were here so closely interlinked that it was not infrequently difficult or impossible to draw a borderline. The less troublesome an intervention is and the greater its value for the patient is judged to be, the less is the need for further ethical evaluation.
In our experience it is relatively unusual for trials to be carried out on patients where the aim did not have any relationship with the patient-care situation. This type of research has no connection with the problems here discussed.
The follow-up study Applications and committee minutes were examined and, moreover, all heads of experimental staff were asked to what extent their particular project could be implemented in the way planned and whether any complications arose. With a few exceptions, all the information asked for was obtained.
The report submitted in I977 briefly elucidates the diverse ethical problems confronting medical research. In the report emphasis was placed on an appendix comprising reviews of most of the projects assessed. It was hoped that this compilation would serve as a valuable support to members of our ethical committees or other interested persons who feel the need for orientation on the views adopted by the committees in various situations.
The number of projects assessed was 520, of which I75 involved healthy human subjects and 345 patients. Of the projects about 5o could be characterised as controlled clinical trials. In 24 placebo was used. to, or better than those in common use, he might, in performing a controlled study, be entitled to limit his information if this information seems to be insignificant to the patient. Doing so, he ought to have the sanction of a review committee.
Controlled clnical trials
These standpoints are more restricted than some of the assessments made by the review committees in Sweden up to I974. As I see it, it is the patientdoctor relationship which is the crucial point when dealing with controlled studies. Especially today in the light of the loss of faith in doctors, it is essential that we have an honest and frank relationship with our patients. To restore the confidence in the profession seems just now to be more important than the progress that might be created by some controlled trials. My impression is that these studies are often too In a controlled study the difference is that the decision is not made by the doctor in an arbitrary way, but through a scientifically planned randomised distribution. There is no need to tell the patient that such a method has been used. It has been shown through experience that doing so can give rise to anxiety and insecurity. The prerequisite for randomising is, however, that the doctor, after deciding on the method of treatment informs the patient exactly in the same way as if he had made the decision himself. Even ifparticipating in a controlled study -apart from the randomisation -can be looked upon as 'mere patient care' the group recommends that these type ofstudies are scrutinised by the ethical committee'.
